ArticleEuropean heart journal. Digital health2025
Assessment of photoplethysmography-based blood pressure determinations during long-term and short-term remote cardiac monitoring: the RECAMO study.
Article in European heart journal. Digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05899959 (Remote Cardiac Monitoring by the Corsano CardioWatch 287-2 Evaluation Study), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Remote Cardiac Monitoring by the Corsano CardioWatch 287-2 Evaluation Study
Who cites it
3 citing papers in PubMed.
- Multimodal Wearable and Survey Data Reveal Distinct Physiologic Profiles in Hypermobile-Ehlers Danlos Syndrome for Screening Advancements.medRxiv : the preprint server for health sciences · 2026Article
- AI-Enabled Sensor Technologies for Remote Arrhythmic Monitoring in High-Risk Cardiomyopathy Genotypes.Sensors (Basel, Switzerland) · 2026Review
- Precision cardiovascular medicine with big data and AI.NPJ digital medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Cardiovascular diseases are a global health crisis, with hypertension as a significant risk factor. Traditional cuff-based blood pressure measurements have various limitations, prompting the exploration of photoplethysmography as an alternative for continuous monitoring. This study aimed to assess a cuff-calibrated wrist-worn photoplethysmography-based blood pressure device against European Society of Hypertension recommendations. Methods and results: The study assessed photoplethysmography-based blood pressure measurement stability over 28 days in 150 patients by comparing measurements of the wrist-worn photoplethysmography-based device against three daily automated reference blood pressure measurements. Additionally, awake-asleep blood pressure changes were analysed in 40 patients receiving 24-h ambulatory blood pressure monitoring. Data analysis included overall accuracy and recalibration needs during long-term monitoring, the accuracy of monitoring awake-asleep blood pressure changes, and resilience against hydrostatic pressure changes due to variations in device position. Across 28 days, mean errors of 3.84 mmHg (SD 4.46) for systolic and 4.08 mmHg (SD 3.97) for diastolic blood pressure were achieved. Before recalibration on Day 28, mean errors were 2.49 (SD 3.10) for systolic and 2.98 (SD 3.48) for diastolic blood pressure. Awake-asleep blood pressure change accuracy was demonstrated with mean errors of 2.36 (SD ± 2.40) for systolic and 2.17 (SD ± 2.13) for diastolic blood pressure. Hydrostatic pressure testing indicated resilience against changes in device position. Conclusion: The studied wrist-worn photoplethysmography-based device demonstrated accurate and stable blood pressure monitoring over 28 days, during awake-asleep blood pressure changes and hydrostatic pressure changes. These findings support the device's potential for remote patient monitoring. Study registration: ClinicalTrials.gov identifier: NCT05899959.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.